As immune infiltrate correlates with overall survival and has been shown to correlate with responsiveness to anti-PD-1 and anti-CTLA-4 immunotherapy, we then investigated the significance of such neutrophil signatures in three publicly available immunotherapy-treated melanoma cohorts (n = 119)5,19,26,27. Here, PDCD1 is linked to melanoma.